Related Experiment Video

Updated: May 2, 2026

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
14:15

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

25.7K

Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?

Tim F Greten

    Gut
    |March 18, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    Pancreatic Cancer

    More Related Videos

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
    06:21

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

    Published on: November 19, 2019

    13.3K
    Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
    07:55

    Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

    Published on: January 17, 2025

    1.8K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
    14:15

    Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

    Published on: June 18, 2012

    25.7K
    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
    06:21

    Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

    Published on: November 19, 2019

    13.3K
    Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
    07:55

    Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

    Published on: January 17, 2025

    1.8K

    Related Concept Videos

    Cancer Stem Cells and Tumor Maintenance02:40

    Cancer Stem Cells and Tumor Maintenance

    4.3K
    Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
    Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
    4.3K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    4.0K
    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    4.0K

    Articles linked to this work by shared authors, journal, and citation graph.

    Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes.

    eGastroenterology·2026

    Engineering CAR T Cells for Hepatocellular Carcinoma Recurrence after Liver Transplantation.

    bioRxiv : the preprint server for biology·2026

    Chimeric antigen receptor therapy for hepatocellular carcinoma.

    Seminars in immunology·2026

    Pan-microbial serological repertoire as a biomarker of immunotherapy response in hepatocellular carcinoma.

    Journal for immunotherapy of cancer·2025

    Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

    Cancer letters·2025

    Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts.

    Gut·2026

    Microbiota-host genetic interactions modulate MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions.

    Gut·2026

    Regulatory T cells in autoimmune liver diseases.

    Gut·2026

    Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.

    Gut·2026

    Rewinding the gut clock: from chronodisruption to targeted therapies.

    Gut·2026

    Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.

    Gut·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us